Mazars, the international audit, tax and advisory firm, revealed that it has acted as M&A advisor to the shareholders of MedPolonia in securing an investor – the LUX MED Group. The sales transaction was finalised on 21 April 2022.
The MedPolonia company, based in Poznań, operates a general hospital, three specialist outpatient clinics and primary care centres, as well as an expanded Clinical Research Centre. The hospital, one of the largest private facilities of its kind in the Wielkopolska region, has two operating rooms and a modern endoscopy lab. Annually, it performs about 3 thousand operations and 1.5 thousand gastrointestinal endoscopies. The outpatient clinics include 40 specialty clinics, where approximately 70,000 medical consultations are performed per year.
The LUX MED Group is the market leader in private healthcare services in Poland and part of the international Bupa Group, which operates as an insurer and healthcare provider worldwide. The LUX MED Group provides comprehensive outpatient, diagnostic, rehabilitation, dental, psychological, hospital and long-term care services to more than 2,500,000 patients in more than 270 outpatient facilities and 14 hospitals.
Aleksandra Wysoczyńska, President of the Management Board of MedPolonia and Seller comments: “Thanks to the dedicated work of the Mazars Financial Advisory team led by Jacek Byrt, Partner and Bartosz Łuczak, Senior Manager, our transaction was closed in a competitive and dynamic sales process on terms satisfactory to the partners. The Company is now in the good hands of the LUX MED Group, a leader in the market for private healthcare services in Poland.”
Jacek Byrt, Partner leading the Mazars Financial Advisory Department comments on Mazars’ transactional support: “We have provided our client with comprehensive support in MedPolonia sale process, from introducing the company to potential investors, through managing the competitive transaction process, to structuring the transaction and negotiating the final agreement. We congratulate both parties on the success of the deal.”
The transaction of sale of 100% shares of MedPolonia to the LUX MED Group closed on 21 April 2022.